Switch theme
Sign up to access all valuation multiples
Cofoe Medical Technology Co Ltd is engaged in the research and development, production, sales and service of home medical equipment.
2009
n/a
LTM Revenue $447M
LTM EBITDA $78.2M
$711M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Cofoe Medical has a last 12-month revenue (LTM) of $447M and a last 12-month EBITDA of $78.2M.
In the most recent fiscal year, Cofoe Medical achieved revenue of $414M and an EBITDA of $76.6M.
Cofoe Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cofoe Medical valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $447M | XXX | $414M | XXX | XXX | XXX |
| Gross Profit | $230M | XXX | $215M | XXX | XXX | XXX |
| Gross Margin | 51% | XXX | 52% | XXX | XXX | XXX |
| EBITDA | $78.2M | XXX | $76.6M | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 18% | XXX | XXX | XXX |
| EBIT | $57.7M | XXX | $50.2M | XXX | XXX | XXX |
| EBIT Margin | 13% | XXX | 12% | XXX | XXX | XXX |
| Net Profit | $48.7M | XXX | $43.3M | XXX | XXX | XXX |
| Net Margin | 11% | XXX | 10% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Cofoe Medical's stock price is CNY 33 (or $5).
Cofoe Medical has current market cap of CNY 6.9B (or $955M), and EV of CNY 5.1B (or $711M).
See Cofoe Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $711M | $955M | XXX | XXX | XXX | XXX | $0.23 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Cofoe Medical has market cap of $955M and EV of $711M.
Cofoe Medical's trades at 1.7x EV/Revenue multiple, and 9.3x EV/EBITDA.
Equity research analysts estimate Cofoe Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cofoe Medical has a P/E ratio of 19.6x.
See valuation multiples for Cofoe Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $955M | XXX | $955M | XXX | XXX | XXX |
| EV (current) | $711M | XXX | $711M | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 9.1x | XXX | 9.3x | XXX | XXX | XXX |
| EV/EBIT | 12.3x | XXX | 14.2x | XXX | XXX | XXX |
| EV/Gross Profit | 3.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 19.6x | XXX | 22.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 9.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCofoe Medical's last 12 month revenue growth is 19%
Cofoe Medical's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Cofoe Medical's rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cofoe Medical's rule of X is 66% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Cofoe Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 19% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | 22% | XXX | 22% | XXX | XXX | XXX |
| Rule of 40 | 34% | XXX | 38% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 66% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 20% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 40% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cofoe Medical acquired XXX companies to date.
Last acquisition by Cofoe Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Cofoe Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Cofoe Medical founded? | Cofoe Medical was founded in 2009. |
| Where is Cofoe Medical headquartered? | Cofoe Medical is headquartered in China. |
| Is Cofoe Medical publicy listed? | Yes, Cofoe Medical is a public company listed on SHE. |
| What is the stock symbol of Cofoe Medical? | Cofoe Medical trades under 301087 ticker. |
| When did Cofoe Medical go public? | Cofoe Medical went public in 2021. |
| Who are competitors of Cofoe Medical? | Similar companies to Cofoe Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Cofoe Medical? | Cofoe Medical's current market cap is $955M |
| What is the current revenue of Cofoe Medical? | Cofoe Medical's last 12 months revenue is $447M. |
| What is the current revenue growth of Cofoe Medical? | Cofoe Medical revenue growth (NTM/LTM) is 19%. |
| What is the current EV/Revenue multiple of Cofoe Medical? | Current revenue multiple of Cofoe Medical is 1.6x. |
| Is Cofoe Medical profitable? | Yes, Cofoe Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Cofoe Medical? | Cofoe Medical's last 12 months EBITDA is $78.2M. |
| What is Cofoe Medical's EBITDA margin? | Cofoe Medical's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Cofoe Medical? | Current EBITDA multiple of Cofoe Medical is 9.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
